A20-15 - Daratumumab - Extract of dossier assessment - Version 1.0
NEW TREATMENT OPTIONS FOR PATIENTS WITH ADVANCED RELAPSE / REFRACTORY MULTIPLE MYELOMA
Multiple Myeloma Hub on Twitter: "PFS from 1st randomization: 53% reduction in risk of progression or death with D-VTd. OS: data immature. Non-hematological toxicity same between arms. Philippe Moreau concludes D- VTd should
Freedom of Information Request FOI 22-166 3rd May 2022 I am investigating the use of targeted therapies in blood-related cancers
Role of Anti–CD38 Antibody Therapy in Induction and Maintenance in Newly Diagnosed Multiple Myeloma: How to Adopt in Clinical Practice
Ο χρήστης Vincent Rajkumar στο Twitter: "I am very impressed with the CASSIOPEIA Dara-VTD vs VTD trial. Especially HR post adjustment for maintenance & the trend for OS I will consider a
Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
Newly Diagnosed: D + VTD Treatment | DARZALEX® IV (daratumumab)
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Cureus | Efficacy of Daratumumab-Based Regimens Compared to Standard of Care in Transplant-Eligible Multiple Myeloma: A Meta-Analysis | Article
Dara+IRD As Extended Induction and Consolidation Followed By Lenalidomide Maintenance
Twitter \ Multiple Myeloma Hub على تويتر: "CONGRESS | #COMy20 | MM Hub SC member Philippe Moreau, @UnivNantes, discussed novel induction regimens to optimize outcomes to transplant. The benefit of KRd, Dara-VTd
Treatment indications of multiple myeloma VTD : Bortezomib -Thalidomide... | Download Scientific Diagram
Presentazione di PowerPoint
NEW TREATMENT OPTIONS FOR PATIENTS WITH ADVANCED RELAPSE / REFRACTORY MULTIPLE MYELOMA
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Vincent Rajkumar on Twitter: "Philippe Moreau is rubbing it in! IFM accrued 1085 patient with Newly Diagnosed MM in to the Dara-VTD vs VTD trial in 2 years! Astounding! We cannot do
Current status of autologous stem cell transplantation for multiple myeloma | Blood Cancer Journal
Trapianto autologo in tutti i pazienti?
How I treat relapsed multiple myeloma - ScienceDirect
Newly Diagnosed: D + VMP Treatment | DARZALEX® IV (daratumumab)
MGUS E MIELOMA MULTIPLO: UPDATE DIAGNOSTICO- TERAPEUTICO
